Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Ark Therapeutics Group plc       GB0034251727

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Premier Veterinary Group Plc provides veterinary health care services.It operates through two businesses: the operation of veterinary practices and the provision of products and services to third party practices through its subsidiary Premier Vet Alliance.The company also administers a small animal... 
Sector
Pharmaceuticals
Calendar

- No events available -

More about the company
Latest news on ARK THERAPEUTICS GROUP PLC
05/18PREMIER VETERINARY GROUP PLC : half-yearly earnings release
03/10 DIRECTOR DEALINGS : Three Premier Veterinary Directors Sell Shares
03/03 PREMIER VETERINARY : Selling Premier Buying Group To Fund US Expansion
02/24 PREMIER VETERINARY : UK Shareholder Meetings Calendar - Next 7 Days
02/16 PREMIER VETERINARY : Signs Up New US Midwest Distribution Partner
01/31 PREMIER VETERINARY : Agrees New Loan Note As Pets On Plans Rise In 2016
2016 PREMIER VETERINARY : Confident For Expansion Plans As Annual Loss Widens
2016 PREMIER VETERINARY : Wins New Additions To Premier Pet Care Plan
2016 PREMIER VETERINARY : Signs 3-Year Extension To Contract With Medivet
2016DJPremier Veterinary Signs Dutch Cooperation Agreement With Zoetis
More news
Sector news : Generic Pharmaceuticals
08/22 JOHNSON & JOHNSON : Massive California verdict expands J&J's talc battlefield
08/22 JOHNSON & JOHNSON : Massive California verdict expands J&J's talc battlefield
08/22DJBAYER : Monsanto's $57 Billion Megadeal Faces Closer EU Scrutiny -- 2nd Update
08/22 EU starts in-depth probe of Bayer, Monsanto deal
08/22DJJOHNSON & JOHNSON : J&J Wades Into Death Penalty Debate for the First Time -- Up..
More sector news : Generic Pharmaceuticals
Income Statement Evolution
Consensus
 
Mean consensus BUY
Number of Analysts 1
Average target price 3,05  GBP
Spread / Average Target 179%
EPS Revisions
Managers
NameTitle
Dominic Stephen Tonner Chief Executive Officer & Executive Director
Juliet Thompson Independent Non-Executive Chairman
Will Evans Chief Financial Officer
Graham Dick Independent Non-Executive Director
Iain Gladstone Ross Non-Executive Director